Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2090 (LINC02090) is a gene that encodes a long intergenic non-coding RNA—a type of RNA molecule greater than 200 nucleotides that does not code for protein and does not overlap annotated protein-coding loci[1][3][5]. LINC02090 belongs to the lincRNA family and may function in regulating the expression of nearby genes, modulating chromatin structure, and contributing to transcriptional control, though its specific biological and disease associations are currently unknown. LincRNAs are increasingly recognized for their diverse functions in fine-tuning gene expression, genome architecture, and tissue-specific regulatory roles, but LINC02090 itself remains uncharacterized with respect to detailed functional or clinical significance[3].
None. Since no drugs target this RNA, mechanisms of action do not apply.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2090 (LINC02090).